Integrating Palliative Care and Modern Palliative Care Tools Into the Care of Patients With Pancreas Cancer

Withdrawn before enrolling

Conditions studied: Pancreas Cancer

In brief

The main purpose of this study is to evaluate the acceptance by patients with metastatic pancreas cancer of integrating palliative care with usual cancer treatment. Palliative care intervention will involve use of pancreas cancer-specific decision aides (iPC3)about prognosis, treatment choices, and advance care planning for patients facing a treatment decision as well as symptom assessments. We hypothesize that palliative care consultations with iPC3 will be accepted, symptoms can be diminished, information can be received in a way that improves choices, and that the quality of care can be improved.

Key facts

Study ID

NCT01784081

Run by

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

People needed

0

Starts

2014-04-01

Expected to finish

2015-06-01

Last updated by the study team

2016-06-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients with metastatic pancreas cancer will be eligible, ages 18 and above.
• There is no limit to the amount of prior therapy for metastatic disease.
• Ability to understand and the willingness to sign a written informed consent document and to answer a questionnaire.
• English speakers.

You may not qualify if…

• Patients who have tumors other than metastatic pancreas cancer.
• Patients who actively decline participation or who are judged to be in distress before the interview.
• Patients who are pregnant.

Where it is running

• Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.